CERE
Cerevel Therapeutics Holdings, Inc.
Perceptive Advisors LLC bought $49.9M of Cerevel Therapeutics Holdings, Inc.
Director
Bought$49,875,000
$35.00Price
1,425,000Shares
+28%Stake
What CERE did for a copier
Prices for CERE after this filing aren't in yet.
Perceptive Advisors LLC's record
30 other buys with 3 months of prices since 2018: on average −8.2% against the S&P 500, and 9 of 30 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Tue, Aug 16. Filed Thu, Aug 18, 5:10 PM ET, after the close. Not investment advice.